Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Alanine aminotransferase increased
ADR ID BADD_A00134
ADR Hierarchy
13      Investigations
13.03      Hepatobiliary investigations
13.03.04      Hepatobiliary function diagnostic procedures
13.03.04.005      Alanine aminotransferase increased
Description A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen. [CTCAE]
MedDRA Code 10001551
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Alanine aminotransferase increase | Alanine aminotransferase increased | ALT increased | Glutamic-pyruvate transaminase increased | Glutamic-pyruvic transam incr | Glutamic-pyruvic transaminase increased | GPT inc | GPT increased | GPT increased transient | Serum glutamic-pyruvic ta incr | Serum glutamic-pyruvic transaminase increased | SGPT increased | Transaminase glutamic-pyruvic increased | Serum glutamic-pyruvic ta increased | ALT flare up | ALT high
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02334Vandetanib--
BADD_D02335Vardenafil--
BADD_D02342Vedolizumab--
BADD_D02346Venlafaxine--
BADD_D02362Vinflunine--
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
BADD_D02377Zafirlukast--
BADD_D02379Zaleplon--
BADD_D02384Zileuton--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02396Zonisamide--
BADD_D02398Zuclopenthixol--
The 16th Page    First    Pre   16    Total 16 Pages